Morgan Stanley reclassified AIA (01299) as the preferred insurance stock, while PICC GROUP (01339) was upgraded to "hold".
Daiwa published a report stating that AIA Group Insurance (01299) is the top choice for insurance stocks in Hong Kong and mainland China, with a "Buy" rating maintained and a target price of 88 yuan unchanged.
Morgan Stanley released a report stating that AIA (01299) is the top choice for insurance stocks in Hong Kong and mainland China, maintaining a "overweight" rating with a target price of HK$88. At the same time, the rating for PICC GROUP (01339) has been upgraded from "in line with the market" to "overweight", with a target price raised from HK$3.1 to HK$4.1.
Morgan Stanley believes that the new business value of insurance stocks in Hong Kong and mainland China is expected to remain healthy, and in the long term, insurance companies will continue to remove risks with disciplined investment strategies to strengthen their balance sheets and efficient operations. It is expected that as leverage is gradually removed, investors will reassess high-quality insurance stocks.
Morgan Stanley believes that AIA's foundation remains solid, and a potential interest rate cut by the Federal Reserve may benefit the enterprise value (EV) and profits of Hong Kong stocks and AIA, as well as insurance product sales. Morgan Stanley sees potential for AIA to expand its operations in mainland China to more provinces, which they see as a catalyst.
Morgan Stanley also noted that PICC GROUP's subsidiary, PICC P&C (02328), has stable operations, a healthy combined ratio (CoR), and a strong return on equity, remaining a major contributor to the group's profits. The quality of the life and health insurance business has significantly improved, and with the support of lower pricing rates, this trend is expected to continue. Additionally, with the group's disciplined investment strategy and historically minimal risks, its valuation remains attractive.
Related Articles

HK Stock Market Move | C HIGHPRECISION (00591) fell more than 14%, with an estimated annual net profit of about 16 to 19 million.

CITIC Securities: Mainland pharmaceutical industry has not turned the corner but is optimistic, SINOPHARM (01099) is the top choice.

HK Stock Market Move | CHINA AEROSPACE (00031) rises by over 14%, Nantong Kangyuan Integrated Circuit Packaging Substrate Project gradually lands, company may enter top three in domestic substrate industry.
HK Stock Market Move | C HIGHPRECISION (00591) fell more than 14%, with an estimated annual net profit of about 16 to 19 million.

CITIC Securities: Mainland pharmaceutical industry has not turned the corner but is optimistic, SINOPHARM (01099) is the top choice.

HK Stock Market Move | CHINA AEROSPACE (00031) rises by over 14%, Nantong Kangyuan Integrated Circuit Packaging Substrate Project gradually lands, company may enter top three in domestic substrate industry.

RECOMMEND

Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
11/09/2025

Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
11/09/2025

Anti-Involution Policies Deliver Results as August Price Indicators Improve
11/09/2025